DA Davidson Reaffirms Buy Rating for SunOpta (NASDAQ:STKL)
SunOpta (NASDAQ:STKL – Get Free Report) (TSE:SOY)‘s stock had its “buy” rating reaffirmed by analysts at DA Davidson in a research report issued to clients and investors on Thursday, Benzinga reports. They presently have a $9.00 target price on the stock. DA Davidson’s price objective would indicate a potential upside of 40.19% from the company’s […]
Biomea Fusion (NASDAQ:BMEA) Raised to “Strong-Buy” at EF Hutton Acquisition Co. I
EF Hutton Acquisition Co. I upgraded shares of Biomea Fusion (NASDAQ:BMEA – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday, Zacks.com reports. A number of other equities research analysts have also weighed in on BMEA. HC Wainwright raised their price objective on shares of Biomea Fusion from $15.00 […]
BP (NYSE:BP) Rating Lowered to Sector Perform at Scotiabank
BP (NYSE:BP – Get Free Report) was downgraded by research analysts at Scotiabank from a “sector outperform” rating to a “sector perform” rating in a research note issued to investors on Thursday, MarketBeat Ratings reports. They currently have a $36.00 price target on the oil and gas exploration company’s stock, down from their prior price […]
Accolade (NASDAQ:ACCD) PT Lowered to $6.00
Accolade (NASDAQ:ACCD – Get Free Report) had its price objective decreased by Wells Fargo & Company from $7.00 to $6.00 in a note issued to investors on Friday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s price target points to a potential upside of 59.15% from […]
PACCAR (NASDAQ:PCAR) Price Target Cut to $103.00
PACCAR (NASDAQ:PCAR – Get Free Report) had its target price decreased by equities researchers at Truist Financial from $107.00 to $103.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage currently has a “hold” rating on the stock. Truist Financial’s target price indicates a potential downside of 0.60% from the stock’s previous […]
AXIS Capital (NYSE:AXS) PT Raised to $95.00
AXIS Capital (NYSE:AXS – Get Free Report) had its target price boosted by Jefferies Financial Group from $88.00 to $95.00 in a research note issued to investors on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the insurance provider’s stock. Jefferies Financial Group’s target price would indicate a potential upside of 18.82% […]
Accolade (NASDAQ:ACCD) PT Lowered to $7.00
Accolade (NASDAQ:ACCD – Get Free Report) had its price objective reduced by equities research analysts at Canaccord Genuity Group from $13.00 to $7.00 in a report issued on Wednesday, Benzinga reports. The brokerage currently has a “buy” rating on the stock. Canaccord Genuity Group’s price objective indicates a potential upside of 80.88% from the company’s […]
Jefferies Financial Group Boosts Fortune Brands Innovations (NYSE:FBIN) Price Target to $111.00
Fortune Brands Innovations (NYSE:FBIN – Get Free Report) had its price objective hoisted by investment analysts at Jefferies Financial Group from $100.00 to $111.00 in a research report issued on Wednesday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Jefferies Financial Group’s target price would suggest a potential upside of 27.15% […]
Jefferies Financial Group Initiates Coverage on Consolidated Edison (NYSE:ED)
Investment analysts at Jefferies Financial Group initiated coverage on shares of Consolidated Edison (NYSE:ED – Get Free Report) in a research note issued to investors on Wednesday, Marketbeat reports. The brokerage set a “hold” rating and a $108.00 price target on the utilities provider’s stock. Jefferies Financial Group’s target price points to a potential upside […]
Jefferies Financial Group Lowers Trex (NYSE:TREX) Price Target to $73.00
Trex (NYSE:TREX – Get Free Report) had its price objective reduced by equities research analysts at Jefferies Financial Group from $77.00 to $73.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The brokerage presently has a “hold” rating on the construction company’s stock. Jefferies Financial Group’s price target points to […]
Travere Therapeutics (NASDAQ:TVTX) PT Raised to $20.00 at Bank of America
Travere Therapeutics (NASDAQ:TVTX – Get Free Report) had its target price lifted by equities researchers at Bank of America from $18.00 to $20.00 in a research report issued to clients and investors on Wednesday, Benzinga reports. The firm currently has a “buy” rating on the stock. Bank of America‘s target price would indicate a potential […]
last updated on 12 Oct 10:22